Transformations in Cancer Care: Innovative Approaches for Better Experiences and Outcomes

Alan Lubeck has been employed at Sanofi as Head of US Benefits at Sanofi for the past 7 yrs. at their Bridgewater, NJ office.  He is responsible for H&W, retirement and well-being benefits including strategy, design and operations.   Prior to coming to Sanofi, Alan led the global benefits function for 10 years at a F500 financial services company.   He also led up retirement programs at a large payroll provider for a few years and spent 14 yrs in consulting on retirement actuarial side.

Ayelet Mosaffi Hutson, North America Director, Total Wellbeing and Global Projects is responsible for developing the wellbeing strategy and programming in North America and for global wellbeing projects. Sanofi is committed to offering benefits and programs that meet the diverse needs of employees and their family members. Ayelet has expanded Sanofi’s benefits to include programs that help employees thrive at work and at home, including digital health benefits, enhanced mental health offerings, family support and more.

Ayelet has worked at Sanofi for more than 20 years and has had various responsibilities in HR – from talent acquisition, talent management, people business partner, continuous improvement to leave management – throughout her tenure with the organization. 

Hannah Menard is the Director of Access Strategy in Oncology, where she leads efforts to shape and execute strategies that improve patient access to innovative cancer therapies. Her focus includes go-to-market strategic components like distribution, shipping, pricing and stakeholder engagement. Prior to her current role, Hannah held several roles across Life Sciences consulting, including experience at both Simon-Kucher and Alvarez and Marsal. At Simon-Kucher, she specialized in pricing and market access strategies across therapeutic areas, with a strong focus on oncology. Her cross-functional expertise spans payer engagement, value demonstration, and benefit design innovation, making her a trusted leader in navigating the evolving access landscape. In her role at Alvarez & Marsal, she helped initiate and grow the Life Sciences Healthcare group. She specialized in strategic growth and resource allocation, helping companies improve operational efficiency and prepare internally for key milestones of life cycle events in the brand.

Ms. Menard holds her MBA from the Crummer Graduate School of Business and earned her BA in Chemistry at Washington University in St. Louis.

Jenn Dale serves as Senior Director of Government Relations at Sanofi. With over a decade of experience in healthcare policy, she has served as an aide on Capitol Hill, represented patient advocacy groups in their advocacy, and was most recently a Director of Government Affairs at GSK. Passionate about improving patient access and affordability, Jenn’s expertise lies in navigating complex healthcare policies and building strategic relationships to advance patient-centric initiatives.

Tom Snow is currently General Manager for US Oncology in the Specialty Care Global Business Unit of Sanofi.  Since joining the company in 2012, he has served as Global Franchise Head, Neurology and Rare Blood Disorders; Head of Global Commercial Strategy for MS; and Regional Commercial Head for Neurology and Immunology in Europe.  He has overseen several successful global and regional launches for Sanofi, Aubagio, Lemtrada, ALTUVIIIO, Enjaymo, Dupixent, and Kevzara.

Before joining Sanofi Genzyme, Tom spent 9 years with Merck Serono in the US and Switzerland, where he headed global strategic marketing for Merck Serono’s MS franchise.   

Tom received his BA in English and Economics from Amherst College, and his MBA from Babson College, both in the US. 

In his “spare time,” Tom enjoys tennis, running, listening to music, playing the drums, and reading books.  He also publishes a blog about spirituality and business travel (theabsoluteceiling.blogspot.com) which receives tens of unique visitors per month.

Kim Thiboldeaux is a seasoned, passionate health care leader with experience in both the private and non-profit sectors, spanning multiple disease areas and health care topics including HIV and AIDS, organ transplant, oncology, caregiving, patient navigation, and health equity.

Kim served as CEO of the Cancer Support Community (CSC) for 20 years, from 2000-2020, leading a global nonprofit network that operates at 175 locations, including CSC and Gilda’s Club centers, and in multiple hospitals and cancer clinics. Combined with a toll-free Helpline, a Research Institute, and a DC-based Policy Institute, Kim grew this network of professionally-led services five-fold during her tenure. In her last year as CEO, the organization provided more than $50 million in free support and navigation services to patients and families.

Kim’s service includes appointments to the nation’s premier health care panels and boards. In 2019, Dr. Francis S. Collins, Director of the National Institutes of Health, appointed Kim to the Novel and Exceptional Technology and Research Advisory Committee. This panel is focused on providing advice and serving as a transparent forum for discussion of the scientific, safety, and ethical issues associated with emerging biotechnologies. In 2017, Kim was appointed to serve on the Biden Cancer Initiative’s Board of Directors.

In serving as a patient advocate on these high-profile boards and panels, Kim has brought attention to inequities in our health care system. In 2019, she joined Navajo Nation President Jonathan Nez, Dr. Jill Biden, and leaders of the Tuba City Regional Health Care Corporation in Arizona to mark the opening of the first-ever full-time cancer and support center on an American Indian Reservation. Kim helped convene key Navajo Nation leaders, private sector supporters, and other officials to establish this culturally-adapted program located in an area larger than the state of West Virginia. That work led to the opportunity to develop a full-length, feature documentary, Navajo Nation USA, about the cancer center and the triumphs and challenges of the Navajo people. Kim is Executive Producer and Writer on the film (www.NavajoNationUSA.com).

In 2020, Stand Up To Cancer appointed Kim to its Equity Breakthrough Research Review Team, focusing on cancers affecting underrepresented populations. In 2019, the International Psychosocial Oncology Society presented Kim with the President’s Community Award for Distinguished Contributions at its Global Congress in Canada.

Kim has led numerous other initiatives to help patients and families in need. Most notably, she launched an emergency fund in the wake of the COVID-19 pandemic that provided financial relief grants to thousands of patients affected by the economic downturn and expanded the organization’s professionally-staffed Helpline as the call volume nearly doubled. In addition, as part of a two-year collaboration she led with Airbnb, more than 3,000 patients in need were provided free housing while traveling for treatment.

Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of  social, cultural and racial determinants of health.

Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.

Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.